Metagenomi, Inc. Common Stock (MGX) financials · rev $25.2M
Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT
Metagenomi, Inc. Common Stock (MGX) rev $25.2M.
| Line | FY2025 | FY2024 |
|---|---|---|
| Revenue | $25.2M | $52.3M |
| Operating Income | -$96.0M | -$88.9M |
| Net Income | -$87.9M | -$78.1M |
| EPS (Diluted) | -$2.36 | -$2.36 |
| Line | FY2025 | FY2024 |
|---|---|---|
| Total Assets | $221.1M | $324.6M |
| Current Assets | $165.5M | $258.0M |
| Cash & Equivalents | $41.7M | $27.4M |
| PP&E | $12.3M | $17.7M |
| Total Liabilities | $62.5M | $89.7M |
| Current Liabilities | $22.9M | $37.3M |
| Shareholders' Equity | $158.6M | $234.9M |
| Retained Earnings | -$310.9M | -$223.0M |
| Line | FY2025 | FY2024 |
|---|---|---|
| Operating Cash Flow | -$88.9M | -$109.1M |
| CapEx | $574.0K | $3.11M |
| Investing Cash Flow | $103.5M | -$88.2M |
| Financing Cash Flow | -$356.0K | $84.0M |
| Net Change in Cash | $14.3M | -$113.2M |
| Free Cash Flow | -$89.5M | -$112.2M |
FAQ
What is MGX P/E and revenue?
Metagenomi, Inc. Common Stock (MGX) rev $25.2M.
What is MGX revenue?
Metagenomi, Inc. Common Stock last cached revenue is $25.2M (FY2025).
Is MGX profitable?
Metagenomi, Inc. Common Stock last cached net income is -$87.9M (FY2025).
What are MGX total assets?
Metagenomi, Inc. Common Stock last cached total assets are $221.1M (FY2025).
What is MGX free cash flow?
Metagenomi, Inc. Common Stock last cached free cash flow is -$89.5M (FY2025).
Not investment advice. Cached statements, not a live tape.